[1]赵建美,邵 岩.血必净治疗社区获得性肺炎的研究进展[J].医学信息,2018,31(02):20-22.[doi:10.3969/j.issn.1006-1959.2018.02.009]
　ZHAO Jian-mei,SHAO Yan.Research Progress of Xuebijing in Treating Community Acquired Pneumonia[J].Medical Information,2018,31(02):20-22.[doi:10.3969/j.issn.1006-1959.2018.02.009]
点击复制

血必净治疗社区获得性肺炎的研究进展()

医学信息[ISSN:1006-1959/CN:61-1278/R]

卷:
31卷
期数:
2018年02期
页码:
20-22
栏目:
综述
出版日期:
2018-01-15

文章信息/Info

Title:
Research Progress of Xuebijing in Treating Community Acquired Pneumonia
文章编号:
1006-1959（2018）02-0020-03
作者:
赵建美; 邵 岩
天津市滨海新区中医医院内科，天津 300451
Author(s):
ZHAO Jian-mei; SHAO Yan
Department of Internal Medicine,Tianjin Binhai New Area Hospital of Traditional Chinese Medicine,Tianjin 300451,China
关键词:
血必净; 社区获得性肺炎; 革兰氏阴性杆菌; 内毒素
Keywords:
Key words：Xuebijing; Community-acquired pneumonia; Gram-negative bacilli; Endotoxin
分类号:
R563.1
DOI:
10.3969/j.issn.1006-1959.2018.02.009
文献标志码:
A
摘要:
内毒素是革兰氏阴性杆菌细胞壁中的一种成分，叫做脂多糖，脂多糖对宿主有毒性作用。内毒素在社区获得性肺炎患者中的作用不容忽视，尤其是伴有高热、白细胞升高、全身炎症反应综合症的老年和危重症患者。近年来研究证实血必净可拮抗内毒素，降低内毒素引发的血清TNF-α水平，在社区获得性肺炎的治疗中疗效可靠。本文就血必净治疗社区获得性肺炎作用机制及临床应用效果作一综述。
Abstract:
Abstract：Endotoxin is a component of the Gram-negative bacilli cell wall,called lipopolysaccharide,lipopolysaccharide toxic effects on the host.The role of endotoxin in patients with community-acquired pneumonia should not be overlooked,especially in elderly and critically ill patients with fever, leukocytosis,and systemic inflammatory response syndrome.In recent years,studies have shown that Xuebijing can antagonize endotoxin,reduce endotoxin-induced serum levels of TNF-α,in the treatment of community-acquired pneumonia curative effect is reliable.This article reviews the mechanism of Xuebijing in treating community-acquired pneumonia and its clinical application.

参考文献/References:

[1]王宠林.肺炎[M]//陈灏珠,李宗明.内科学.第4版.北京:人民卫生出版社,1996:58.
[2]任桂花.社区获得性革兰氏阴性杆菌肺炎306例临床分析[J].河南科技大学学报(医学版),2012,30(3):208-209.
[3]陶岳多,张智淞,王灿恒,等.老年人革兰氏阴性杆菌肺炎22例临床分析[J].苏州医学院学报,1989,9(1):41-42.
[4]明自强,俞林明,吕银祥,等.血必净注射液治疗脓毒症患者抗炎作用观察[J].现代中西医结合杂志,2007,16(6):731-732.
[5]任雁.不同疾病血浆内毒素含量的测定及结果分析[J].检验医学与临床,2012,9(19):2450-2451.
[6]张建芳,徐修礼,樊新,等.不同疾病患者血浆内毒素含量的测定及结果分析[J].临床检验杂志,2005,23(6):449-450.
[7]左勇.呼吸道感染患者血浆内毒素水平测定的临床价值[J].检验医学与临床,2011,8(7):862-863.
[8]马岳峰,徐正宽,刘志海.脓毒症抗炎治疗的研究进展[J].中华急诊医学杂志,2010,19(2):120-123.
[9]Deng J,Huo D,Wu Q,et al.Xuebijing for paraquat poisoning[J].Cochrane Database Syst Rev,2013,29(7):CD010109.
[10]Cohen J.The immunopathogenesis of sepsis[J].Nature,2002,420(6917):885-891.
[11]Tracey KJ,Fong Y,Hesse DG,et al.Anti-cachectin TNF monoclonal antibodies prevent septic shock during lethal bacteraemia[J].Nature,1987,330(6149):662-664.
[12]Riedemann NC,Neff TA,Guo RF,et al.Protective effects of IL-6 blockade in sepsis are linked to reduced C5a receptor expression[J].J Immunol,2003,170(1):503-507.
[13]龚睿,蒋磊,康凯,等.血必净通过上调血红素氧化酶-1减轻脓毒症诱导肺损伤[J].医学研究杂志,2017,46(2):102-107.
[14]马世堂,刘培勋,龙伟,等.血必净抗炎作用药效物质基础和多靶点作用效应[J].物理化学学报,2009,25(10):2080-2086.
[15]向忠阳,刘永平.血必净注射液治疗医院内获得性肺炎的疗效[J].中国实用医刊,2012,39(7):100.
[16]卢万向.中西药联合治疗老年重症社区获得性肺炎临床体会[J].内蒙古中医药,2012,31(10):21-22.
[17]徐春玲,熊少姝.血必净注射液辅助治疗重症肺炎25例近期疗效观察[J].山东医药,2011,51(31):53-54.
[18]王石磊,邢丽华.血必净注射液佐治社区获得性肺炎的疗效及安全性探究[J].中国医药指南,2013,11(3):8-9.
[19]孔令宜.血必净注射液治疗ICU重症社区获得性肺炎的临床疗效分析[J].天津中医药,2015,32(6):341-343.
[20]汪沁.重症社区获得性肺炎ICU治疗采用血必净注射液的临床分析[J].临床医学研究与实践,2016,1(15):39-40.
[21]李艳丽,李军利,孟鹏飞.血必净辅助治疗重症社区获得性肺炎67例[J].中国现代药物应用,2015,9(23):132-133.
[22]郑秀卿.血必净联合抗生素治疗社区获得性肺炎可缩短住院时间[J].医学信息,2014(29):54-55.
[23]黄种杰,洪原成.血必净治疗细菌性肺炎合并高热128例疗效观察[J].临床肺科杂志,2011,16(4):568-569.

相似文献/References:

[1]包克珍,许云丽.新生儿社区获得性肺炎的临床特征分析[J].医学信息,2018,31(02):184.[doi:10.3969/j.issn.1006-1959.2018.02.072]
　BAO Ke-zhen,XU Yun-li.Clinical Characteristics of Neonatal Community Acquired Pneumonia[J].Medical Information,2018,31(02):184.[doi:10.3969/j.issn.1006-1959.2018.02.072]
[2]赵建美,邵 岩,李京津.电脑中频药透对治疗老年社区获得性肺炎的疗效分析[J].医学信息,2018,31(03):146.[doi:10.3969/j.issn.1006-1959.2018.03.052]
　ZHAO Jian-mei,SHAO Yan,LI Jing-jin.Analysis of the Efficacy of Computer Medium Frequency Drug Penetration in the Treatment of Elderly Community-acquired Pneumonia[J].Medical Information,2018,31(02):146.[doi:10.3969/j.issn.1006-1959.2018.03.052]
[3]曹立杰,杨林瀛,于国云,等.N-末端脑钠肽前体与社区获得性肺炎患者严重程度关系研究[J].医学信息,2018,31(04):1.[doi:10.3969/j.issn.1006-1959.2018.04.001]
　CAO Li-jie,YANG Lin-ying,YU Guo-yun,et al.Study on the Relationship between N-terminal Brain Natriuretic Peptide Precursors and the Severity of Community-acquired Pneumonia[J].Medical Information,2018,31(02):1.[doi:10.3969/j.issn.1006-1959.2018.04.001]
[4]俞 静,赵 红,金 晶,等.社区获得性肺炎胸部CT中反晕征的初步研究[J].医学信息,2022,35(10):109.[doi:10.3969/j.issn.1006-1959.2022.10.026]
　YU Jing,ZHAO Hong,JIN Jing,et al.Preliminary Study of Reversed Halo Sign in Chest CT of Community-acquired Pneumonia[J].Medical Information,2022,35(02):109.[doi:10.3969/j.issn.1006-1959.2022.10.026]
[5]武珊珊.喜炎平注射液治疗社区获得性肺炎临床疗效的Meta分析[J].医学信息,2018,31(14):64.[doi:10.3969/j.issn.1006-1959.2018.14.020]
　WU Shan-shan.Meta-analysis of Clinical Efficacy of Xiyanping Injection in the Treatment of Community-acquired Pneumonia[J].Medical Information,2018,31(02):64.[doi:10.3969/j.issn.1006-1959.2018.14.020]
[6]徐安林,刘 忠.不同配比的哌拉西林-他唑巴坦治疗 老年性社区获得性肺炎的疗效对比[J].医学信息,2018,31(15):129.[doi:10.3969/j.issn.1006-1959.2018.15.041]
　XU An-lin,LIU Zhong.Comparison of the Efficacy of Different Ratios of Piperacillin-tazobactam in Elderly Community Acquired Pneumoni[J].Medical Information,2018,31(02):129.[doi:10.3969/j.issn.1006-1959.2018.15.041]
[7]许 俊.慢性阻塞性肺疾病急性加重期与慢性阻塞性肺疾病并发社区获得性肺炎患者的临床对比[J].医学信息,2018,31(22):118.[doi:10.3969/j.issn.1006-1959.2018.22.033]
　XU Jun.Clinical Comparison of Patients with Acute Exacerbation of Chronic Obstructive Pulmonary Disease and Chronic Obstructive Pulmonary Disease Complicated with Community Acquired Pneumonia[J].Medical Information,2018,31(02):118.[doi:10.3969/j.issn.1006-1959.2018.22.033]
[8]远 颖.成人社区获得性肺炎中医药研究[J].医学信息,2018,31(23):55.[doi:10.3969/j.issn.1006-1959.2018.23.016]
　YUAN Ying.Traditional Chinese Medicine Research on Adult Community Acquired Pneumonia[J].Medical Information,2018,31(02):55.[doi:10.3969/j.issn.1006-1959.2018.23.016]
[9]陈亚南,陈 赛,毛琦善.青壮年与中老年社区获得性肺炎病原体的对比分析[J].医学信息,2019,32(01):145.[doi:10.3969/j.issn.1006-1959.2019.01.045]
　CHEN Ya-nan,CHEN Sai,MAO Qi-shan.Comparative Analysis of Pathogens of Acquired Pneumonia among Young Adults and Middle-aged and Elderly People[J].Medical Information,2019,32(02):145.[doi:10.3969/j.issn.1006-1959.2019.01.045]
[10]张恺悦,陈幼琼.乌司他丁联合血必净对烧伤后脓毒症患者凝血功能及全身炎性反应的影响研究[J].医学信息,2019,32(04):138.[doi:10.3969/j.issn.1006-1959.2019.04.044]
　ZHANG Kai-yue,CHEN You-qiong.Effect of Ulinastatin Combined with Xuebijing on Coagulation Function and Systemic Inflammatory Response in Patients with Sepsis after Burn[J].Medical Information,2019,32(02):138.[doi:10.3969/j.issn.1006-1959.2019.04.044]

更新日期/Last Update: 2018-02-15